Manish Jha is Associate Professor at UT Southwestern Medical Center. OpenAlex indexes 339 publications with 6,333 citations (h-index 38); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.
Data verified 22 Oct 2026
Overview
Updated 22 Oct 2026
Manish Jha, M.B.B.S., is Associate Professor at UT Southwestern Medical Center (Dallas, TX). The public record shows 339 publications with 6,333 citations (h-index 38), centered on Treatment of Major Depression, Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes, Tryptophan and brain disorders. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 5 companies, 2 NIH-funded awards (2021–2026).
- Most recent indexed publication: 2026 · The American journal of psychiatry
- Top research focus: Treatment of Major Depression
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 5 companies
Generated from the cited public record · current as of 22 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 21 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 111.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 22 Oct 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder
Sponsor: University of Texas Southwestern Medical Center
- Tirzepatide for Obesity and Meth Use Disorder
Sponsor: University of Texas Southwestern Medical Center
- Accelerated rTMS for Substance Use Disorder and Depression
Sponsor: University of Texas Southwestern Medical Center
Industry payments
Updated 22 Oct 2026
5 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Neurocrine BioSciences, Inc.Program year20254 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20255 payments
- ABBVIE INC.Program year202514 payments
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Other general anesthetics100%Spravato100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 22 Oct 2026
2 NIH research awards on record, funded 2021–2026 per NIH RePORTER. The latest:
- Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder
Ut Southwestern Medical Center
FY2026$2,792,991UG3DA066252 - Elucidating the Neurocircuitry of Irritability with Ultra-High-Field Neuroimaging to Identify Novel Therapeutic Targets
Ut Southwestern Medical Center
FY2025$182,520K23MH126202 - Elucidating the Neurocircuitry of Irritability with Ultra-High-Field Neuroimaging to Identify Novel Therapeutic Targets
Ut Southwestern Medical Center
FY2024$183,081K23MH126202
Congress activity
Updated 22 Oct 2026
1 congress contribution (2017) across ASCO per OpenAlex. The most recent:
- Implementing mental health screening, assessment, and navigation program in a community-based survivorship program.
ASCO Annual Meeting
ASCO2017Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 22 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Buprenorphine Following Ketamine for Suicidal Ideation: A Bridge to Care from the Emergency Department.
The American journal of psychiatry
Letter2026 - Predictors of trajectories of suicidal thoughts in Texas youth depression and suicide research network youth.
Psychological medicine
Article2026 - Contextualizing the Future DSM: Cross-Cultural, Developmental, and Multi-Informant Considerations.
The American journal of psychiatry
Letter2026 - From Innovation to Implementation: Translating Advances in Psychopharmacology to Clinical Practice.
Focus (American Psychiatric Publishing)
Editorial2026 - The American Society of Clinical Psychopharmacology (ASCP) task force on the deprescribing of psychotropic medications for mood disorders: Delphi expert consensus.
The British journal of psychiatry
Review2026
Most-cited works
by citation count (OpenAlex)- 01
- 02Screening and Management of Depression in Patients With Cardiovascular DiseaseArticle366 citations2019
- 03Association of Depression and Cardiovascular DiseaseArticle302 citations2023
- 04An electroencephalographic signature predicts antidepressant response in major depressionArticle301 citations2020
- 05Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major DepressionArticle277 citations2023
Network
Updated 22 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 22 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
cme.utsouthwestern.edu/node/120205/bio/4562/view
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cme.utsouthwestern.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 22 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cme.utsouthwestern.edu ↗
Editorial & leadership roles
journal and society appointments- Member
Society of Biological Psychiatry
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cme.utsouthwestern.edu ↗ - Member
American Society of Clinical Psychopharmacology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cme.utsouthwestern.edu ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →labs.utsouthwestern.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
Media & interviews
press, podcasts and appearances- UT Southwestern Decoding Depression podcast
Episode 10: A Path for Psychedelic Research (interview with Dr. Madhukar Trivedi and Dr. Manish Jha, host Catherine Huff)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physicianresources.utswmed.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Madhukar Trivedi, MD
UT Southwestern Medical Center
Ildiko Lingvay, MD
UT Southwestern Medical Center
Ambarish Pandey, MD
UT Southwestern Medical Center
Nader Pouratian, MD
UT Southwestern Medical Center
Charles Nemeroff, MD
Dell Medical School
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
Raquel Gur, MD
University of Pennsylvania